|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1998-11-24
|
|
pubmed:abstractText |
The aim of treatment for HIV disease is prolonging survival and improvement in health-related quality of life. Ritonavir is a potent, orally bioavailable HIV protease inhibitor with demonstrated impact on surrogate endpoints, AIDS-defining disease, and mortality.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1495-502
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9727571-Adult,
pubmed-meshheading:9727571-Anti-HIV Agents,
pubmed-meshheading:9727571-Double-Blind Method,
pubmed-meshheading:9727571-Drug Therapy, Combination,
pubmed-meshheading:9727571-Female,
pubmed-meshheading:9727571-HIV Infections,
pubmed-meshheading:9727571-Humans,
pubmed-meshheading:9727571-Male,
pubmed-meshheading:9727571-Middle Aged,
pubmed-meshheading:9727571-Quality of Life,
pubmed-meshheading:9727571-Ritonavir,
pubmed-meshheading:9727571-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group.
|
|
pubmed:affiliation |
Community Research Initiative of New England, Brookline, Massachusetts, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
